In this power-packed episode, we explore the game-changing science behind GLP-1 agonists—the revolutionary drugs transforming treatment for type 2 diabetes and obesity. Discover how decades of research, from hormone discovery to drug innovation, led to today’s best-selling medications like Ozempic, Wegovy, and Rybelsus.But that’s not all—this episode also dives into the digital world with an overview of StoneFly, Inc.’s cutting-edge data storage and disaster recovery solutions. Learn how robust IT infrastructure is helping protect sensitive health data and power next-gen biotech.🔬 Whether you're interested in pharmaceutical innovation, healthcare tech, or secure data systems, this episode delivers insight, inspiration, and actionable takeaways.

GLP-1 Agonists: The Science Behind Weight Loss and Diabetes Breakthroughs